Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort
Abbas, Sascha, Ihle, Peter, Harder, Sebastian, Schubert, IngridТом:
24
Мова:
english
Журнал:
Pharmacoepidemiology and Drug Safety
DOI:
10.1002/pds.3748
Date:
April, 2015
Файл:
PDF, 109 KB
english, 2015
File converter
Більше результатів пошуку
More benefits 
